Kidney Disease News and Research

RSS

CorMedix announces pricing of initial public offering of 1,925,000 units at $6.50 per unit

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, also known as cardiorenal disease, today announced the pricing of its initial public offering of 1,925,000 units at $6.50 per unit (before underwriting discounts and commissions).

26 Mar 2010

Johns Hopkins Hospital completes 100th kidney transplant

Surgeons at The Johns Hopkins Hospital have successfully completed their 100th kidney swap — a procedure popularized here to enlarge the pool of kidneys available for donation and provide organs to patients who might have died waiting for them.

24 Mar 2010

Researchers create audio CDs to encourage physical activity among school students

The National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University $1.22 million to combat childhood obesity in the Bronx.

24 Mar 2010

First reported Australian swine flu case of 2010 – gearing up with protective measures

Swine flu a form of influenza, became a major health scare assuming pandemic proportions starting in Mexico early last year. There were 37,000 confirmed cases in Australia with 5,000 hospitalizations, 700 admissions in intensive care units and 191 deaths.

23 Mar 2010

Inexpensive lab tests can help protect people from chronic kidney disease

No matter what Washington does on health reform, there's a lot you can do to reform your own health -- and two of the best places to start are your kidneys.

20 Mar 2010

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

Most kidney donors and recipients are in favor of exchanging personal health information that may influence success before scheduling a living organ donor transplant, while healthcare professionals are more reluctant, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

19 Mar 2010

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

AMAG Pharmaceuticals, Inc. today announced that one abstract has been accepted for presentation at the National Kidney Foundation 2010 Spring Clinical Meeting being held April 13-17, 2010 in Orlando, FL.

19 Mar 2010

Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics Inc., a U.S. based genetic testing company, announced the immediate availability of its personal Genetic Health Report. This customized and innovative personal genetic health report contains information on more than 70 health conditions, including pharmacogenetics (prescription medication response), propensity for complex disease, and carrier status (pre-pregnancy health).

17 Mar 2010

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

Lipitor® (atorvastatin calcium) 80 mg was associated with a significantly reduced risk of major cardiovascular events compared with Lipitor 10 mg among patients with both coronary heart disease (CHD) and chronic kidney disease (CKD) who were obese or had metabolic syndrome. These data, from two sub-analyses of the Treating to New Targets (TNT) trial that were designed and completed following the completion of TNT, were presented today at the 59th Annual Scientific Session of the American College of Cardiology (ACC) in Atlanta, Ga.

16 Mar 2010

NKF: Certain ethnic minorities are at higher risk for developing CKD

Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD), which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation.

16 Mar 2010

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that data from a phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia (hoFH) were published in The Lancet. This study met its primary endpoint, resulting in an average LDL-C reduction of greater than 100 mg/dL in this very high-risk patient population.

16 Mar 2010

MPP cell population: A new potential target for treating infections and allergies

Millions of people in both the developing and developed world may benefit from new immune-system research findings from the University of Pennsylvania School of Veterinary Medicine.

15 Mar 2010

Growing incidence of chronic kidney disease: Early detection and knowledge of treatment options vital

As the incidence of diabetes and hypertension continues to grow worldwide – and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems – the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical.

From Baxter International Inc. 12 Mar 2010

A new way to control blood pressure

The control of blood pressure is central to people's wellbeing. One in three Australians suffer from high blood pressure (hypertension), a condition which can lead to coronary heart disease, heart failure, stroke and kidney failure.

11 Mar 2010

Researchers identify a novel source of adult stem cells: Foreign body-induced granulation tissue

In a pioneering new study published in the journal Translational Research, Dr. Jilpa Patel and her research group at Hektoen Institute of Medicine and Cook County Hospital in Chicago have isolated and characterized adult stem cells from granulation tissue in rats. A granulation tissue is a new regenerating tissue formed in response to an inert foreign body placed in the subcutaneous tissue.

11 Mar 2010

DaVita recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), has been recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010 for the fifth consecutive year.

11 Mar 2010

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Chronic kidney disease (CKD) afflicts a large number of younger minority adults receiving medical care in settings that serve the uninsured and underinsured (settings collectively known as the healthcare safety net). Poor, minority adults with moderate to severe CKD are also two to four times more likely to progress to kidney failure than non-Hispanic whites.

11 Mar 2010

Review suggests ion exchange resins are not effective for hyperkalemia

For more than half a century, products containing ion exchange resins have been used in patients with dangerously high levels of potassium. However, there is no convincing evidence that these products are actually effective, according to an article appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

10 Mar 2010

Kidney donors have similar survival rates as healthy individuals, says study

An analysis of outcomes for live kidney donors in the U.S. over a 15 year period finds they have similar long-term survival rates compared to healthy individuals who were not kidney donors, according to a study in the March 10 issue of JAMA.

10 Mar 2010

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

It's a silent epidemic that affects millions of Americans. Chronic Kidney Disease (CKD) is a life-threatening illness that can often be treated successfully if found early, and can be detected at an early stage using simple, inexpensive blood and urine tests. As part of its 2010 World Kidney Day awareness program, the physicians of Dallas Nephrology Associates urge everyone to know and track their "kidney number."

9 Mar 2010

Kidney Disease News and Research

CorMedix announces pricing of initial public offering of 1,925,000 units at $6.50 per unit

Johns Hopkins Hospital completes 100th kidney transplant

Researchers create audio CDs to encourage physical activity among school students

First reported Australian swine flu case of 2010 – gearing up with protective measures

Inexpensive lab tests can help protect people from chronic kidney disease

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

Pathway Genomics' personal Genetic Health Report now available

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

NKF: Certain ethnic minorities are at higher risk for developing CKD

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

MPP cell population: A new potential target for treating infections and allergies

Growing incidence of chronic kidney disease: Early detection and knowledge of treatment options vital

A new way to control blood pressure

Researchers identify a novel source of adult stem cells: Foreign body-induced granulation tissue

DaVita recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Review suggests ion exchange resins are not effective for hyperkalemia

Kidney donors have similar survival rates as healthy individuals, says study

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News